The landscape of diabetes management has been significantly reshaped by novel pharmacological agents, among which SGLT-2 inhibitors have emerged as a crucial class. Canagliflozin, identified by its CAS number 842133-18-0, stands out as a prominent example of these therapeutic innovations. As a key pharmaceutical intermediate, understanding its application and sourcing channels is vital for researchers and manufacturers in the pharmaceutical industry.
Canagliflozin functions by selectively inhibiting the sodium-glucose cotransporter 2 (SGLT-2). This mechanism leads to increased urinary glucose excretion, thereby lowering blood glucose levels in patients with type 2 diabetes. Its efficacy in managing hyperglycemia, coupled with potential benefits for cardiovascular and renal health, underscores its importance in modern medicine. For companies involved in the synthesis of such advanced therapies, sourcing high-purity Canagliflozin pharmaceutical intermediate is a critical first step.
When seeking to buy Canagliflozin CAS 842133-18-0, quality and consistency are paramount. Pharmaceutical-grade Canagliflozin typically requires a purity of 99% or higher. Manufacturers in China are a primary source for this compound, offering competitive pricing and large-scale production capabilities. Identifying a reputable Canagliflozin manufacturer in China involves assessing their production standards, quality assurance processes, and ability to provide detailed product documentation, such as Certificates of Analysis.
Procurement managers looking to purchase 444.52 molecular weight pharmaceutical intermediate should prioritize suppliers who can guarantee a stable and reliable supply chain. The journey from intermediate to finished pharmaceutical product is complex, and a dependable Canagliflozin supplier is integral to this process. Engaging with manufacturers allows for direct inquiry regarding pricing, lead times, and bulk order discounts, ensuring cost-effectiveness.
In summary, Canagliflozin (CAS 842133-18-0) represents a significant advancement in diabetes treatment. For pharmaceutical companies, securing a high-quality supply of this intermediate from reliable Chinese manufacturers is essential for driving innovation and meeting the growing demand for effective diabetes management solutions.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.